TORONTO, Ontario – March 25, 2026 – NuGen Medical Devices Inc. (“NuGen”), a leader in needle‑free drug delivery, today announced the filing of a new patent covering a Ready‑to‑Fill (RTF) COP/COC injection nozzle designed specifically for pharmaceutical needle‑free »

NuGen Medical Devices Provides 2025 Year End Update on R&D and Strategic Progress

TORONTO, Ontario – January 16, 2026 – NuGen Medical Devices Inc. (TSXV: NGMD) (“NuGen” or the “Company”), a leader in needle-free subcutaneous drug-delivery »